 | • レポートコード：MRC2-11QY11361 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性疾患管理のグローバル市場について調査・分析したレポートです。種類別（コンサルティングサービス、実装サービス）市場規模、用途別（病院、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性疾患管理の競争状況、市場シェア ・世界の慢性疾患管理市場：種類別市場規模 2015年-2020年（コンサルティングサービス、実装サービス） ・世界の慢性疾患管理市場：種類別市場規模予測 2021年-2026年（コンサルティングサービス、実装サービス） ・世界の慢性疾患管理市場：用途別市場規模 2015年-2020年（病院、在宅医療） ・世界の慢性疾患管理市場：用途別市場規模予測 2021年-2026年（病院、在宅医療） ・北米の慢性疾患管理市場分析：米国、カナダ ・ヨーロッパの慢性疾患管理市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性疾患管理市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性疾患管理市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性疾患管理市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：TriZetto Corporation、Phytel、Pegasystems、AxisPoint Health、Wellcentive、Medecision、HealthSmart Holdings、Allscripts Healthcare Solutions、ZeOmega、Epic Corporation、Harmony Information Systems、Infosys ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Chronic Disease Management which was also known as enhanced primary care earlier is the ongoing care and support which help in managing the health care of patient suffering with chronic disease such as asthma, cancer, diabetes, cardiovascular diseases, stroke, etc. It also require visits and support from the family physician, other primary care provider, community-based programs or referrals to specialist programs and services.
Long-term care centers and rehabilitation centers generally provide chronic disease management services. In chronic care management services, patient are aware of more reliable treatment options. Increase prevalence of chronic disease worldwide is the major factor of market growth for chronic disease management globally.
Market Analysis and Insights: Global Chronic Diseases Management Market
The global Chronic Diseases Management market size is projected to reach US$ 3990.2 million by 2026, from US$ 3664.4 million in 2020, at a CAGR of 8.2%% during 2021-2026.
Global Chronic Diseases Management Scope and Market Size
Chronic Diseases Management market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Diseases Management market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
TriZetto Corporation
Phytel
Pegasystems
AxisPoint Health
Wellcentive
Medecision
HealthSmart Holdings
Allscripts Healthcare Solutions
ZeOmega
Epic Corporation
Harmony Information Systems
Infosys
Market segment by Type, the product can be split into
Consulting Service
Implementation Service
Market segment by Application, split into
Hospitals
Home Care
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Diseases Management Revenue
1.4 Market by Type
1.4.1 Global Chronic Diseases Management Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Consulting Service
1.4.3 Implementation Service
1.5 Market by Application
1.5.1 Global Chronic Diseases Management Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chronic Diseases Management Market Perspective (2015-2026)
2.2 Global Chronic Diseases Management Growth Trends by Regions
2.2.1 Chronic Diseases Management Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Diseases Management Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Diseases Management Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Diseases Management Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Diseases Management Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chronic Diseases Management Players by Market Size
3.1.1 Global Top Chronic Diseases Management Players by Revenue (2015-2020)
3.1.2 Global Chronic Diseases Management Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Diseases Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Diseases Management Market Concentration Ratio
3.2.1 Global Chronic Diseases Management Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Diseases Management Revenue in 2019
3.3 Chronic Diseases Management Key Players Head office and Area Served
3.4 Key Players Chronic Diseases Management Product Solution and Service
3.5 Date of Enter into Chronic Diseases Management Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Diseases Management Historic Market Size by Type (2015-2020)
4.2 Global Chronic Diseases Management Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chronic Diseases Management Market Size by Application (2015-2020)
5.2 Global Chronic Diseases Management Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Diseases Management Market Size (2015-2020)
6.2 Chronic Diseases Management Key Players in North America (2019-2020)
6.3 North America Chronic Diseases Management Market Size by Type (2015-2020)
6.4 North America Chronic Diseases Management Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chronic Diseases Management Market Size (2015-2020)
7.2 Chronic Diseases Management Key Players in Europe (2019-2020)
7.3 Europe Chronic Diseases Management Market Size by Type (2015-2020)
7.4 Europe Chronic Diseases Management Market Size by Application (2015-2020)
8 China
8.1 China Chronic Diseases Management Market Size (2015-2020)
8.2 Chronic Diseases Management Key Players in China (2019-2020)
8.3 China Chronic Diseases Management Market Size by Type (2015-2020)
8.4 China Chronic Diseases Management Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chronic Diseases Management Market Size (2015-2020)
9.2 Chronic Diseases Management Key Players in Japan (2019-2020)
9.3 Japan Chronic Diseases Management Market Size by Type (2015-2020)
9.4 Japan Chronic Diseases Management Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chronic Diseases Management Market Size (2015-2020)
10.2 Chronic Diseases Management Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Diseases Management Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Diseases Management Market Size by Application (2015-2020)
11 India
11.1 India Chronic Diseases Management Market Size (2015-2020)
11.2 Chronic Diseases Management Key Players in India (2019-2020)
11.3 India Chronic Diseases Management Market Size by Type (2015-2020)
11.4 India Chronic Diseases Management Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chronic Diseases Management Market Size (2015-2020)
12.2 Chronic Diseases Management Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Diseases Management Market Size by Type (2015-2020)
12.4 Central & South America Chronic Diseases Management Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 TriZetto Corporation
13.1.1 TriZetto Corporation Company Details
13.1.2 TriZetto Corporation Business Overview
13.1.3 TriZetto Corporation Chronic Diseases Management Introduction
13.1.4 TriZetto Corporation Revenue in Chronic Diseases Management Business (2015-2020))
13.1.5 TriZetto Corporation Recent Development
13.2 Phytel
13.2.1 Phytel Company Details
13.2.2 Phytel Business Overview
13.2.3 Phytel Chronic Diseases Management Introduction
13.2.4 Phytel Revenue in Chronic Diseases Management Business (2015-2020)
13.2.5 Phytel Recent Development
13.3 Pegasystems
13.3.1 Pegasystems Company Details
13.3.2 Pegasystems Business Overview
13.3.3 Pegasystems Chronic Diseases Management Introduction
13.3.4 Pegasystems Revenue in Chronic Diseases Management Business (2015-2020)
13.3.5 Pegasystems Recent Development
13.4 AxisPoint Health
13.4.1 AxisPoint Health Company Details
13.4.2 AxisPoint Health Business Overview
13.4.3 AxisPoint Health Chronic Diseases Management Introduction
13.4.4 AxisPoint Health Revenue in Chronic Diseases Management Business (2015-2020)
13.4.5 AxisPoint Health Recent Development
13.5 Wellcentive
13.5.1 Wellcentive Company Details
13.5.2 Wellcentive Business Overview
13.5.3 Wellcentive Chronic Diseases Management Introduction
13.5.4 Wellcentive Revenue in Chronic Diseases Management Business (2015-2020)
13.5.5 Wellcentive Recent Development
13.6 Medecision
13.6.1 Medecision Company Details
13.6.2 Medecision Business Overview
13.6.3 Medecision Chronic Diseases Management Introduction
13.6.4 Medecision Revenue in Chronic Diseases Management Business (2015-2020)
13.6.5 Medecision Recent Development
13.7 HealthSmart Holdings
13.7.1 HealthSmart Holdings Company Details
13.7.2 HealthSmart Holdings Business Overview
13.7.3 HealthSmart Holdings Chronic Diseases Management Introduction
13.7.4 HealthSmart Holdings Revenue in Chronic Diseases Management Business (2015-2020)
13.7.5 HealthSmart Holdings Recent Development
13.8 Allscripts Healthcare Solutions
13.8.1 Allscripts Healthcare Solutions Company Details
13.8.2 Allscripts Healthcare Solutions Business Overview
13.8.3 Allscripts Healthcare Solutions Chronic Diseases Management Introduction
13.8.4 Allscripts Healthcare Solutions Revenue in Chronic Diseases Management Business (2015-2020)
13.8.5 Allscripts Healthcare Solutions Recent Development
13.9 ZeOmega
13.9.1 ZeOmega Company Details
13.9.2 ZeOmega Business Overview
13.9.3 ZeOmega Chronic Diseases Management Introduction
13.9.4 ZeOmega Revenue in Chronic Diseases Management Business (2015-2020)
13.9.5 ZeOmega Recent Development
13.10 Epic Corporation
13.10.1 Epic Corporation Company Details
13.10.2 Epic Corporation Business Overview
13.10.3 Epic Corporation Chronic Diseases Management Introduction
13.10.4 Epic Corporation Revenue in Chronic Diseases Management Business (2015-2020)
13.10.5 Epic Corporation Recent Development
13.11 Harmony Information Systems
10.11.1 Harmony Information Systems Company Details
10.11.2 Harmony Information Systems Business Overview
10.11.3 Harmony Information Systems Chronic Diseases Management Introduction
10.11.4 Harmony Information Systems Revenue in Chronic Diseases Management Business (2015-2020)
10.11.5 Harmony Information Systems Recent Development
13.12 Infosys
10.12.1 Infosys Company Details
10.12.2 Infosys Business Overview
10.12.3 Infosys Chronic Diseases Management Introduction
10.12.4 Infosys Revenue in Chronic Diseases Management Business (2015-2020)
10.12.5 Infosys Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chronic Diseases Management Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Diseases Management Revenue
Table 3. Ranking of Global Top Chronic Diseases Management Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Diseases Management Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Consulting Service
Table 6. Key Players of Implementation Service
Table 7. Global Chronic Diseases Management Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Chronic Diseases Management Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Chronic Diseases Management Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Chronic Diseases Management Market Share by Regions (2015-2020)
Table 11. Global Chronic Diseases Management Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Chronic Diseases Management Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Chronic Diseases Management Market Growth Strategy
Table 17. Main Points Interviewed from Key Chronic Diseases Management Players
Table 18. Global Chronic Diseases Management Revenue by Players (2015-2020) (Million US$)
Table 19. Global Chronic Diseases Management Market Share by Players (2015-2020)
Table 20. Global Top Chronic Diseases Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Diseases Management as of 2019)
Table 21. Global Chronic Diseases Management by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Chronic Diseases Management Product Solution and Service
Table 24. Date of Enter into Chronic Diseases Management Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 27. Global Chronic Diseases Management Market Size Share by Type (2015-2020)
Table 28. Global Chronic Diseases Management Revenue Market Share by Type (2021-2026)
Table 29. Global Chronic Diseases Management Market Size Share by Application (2015-2020)
Table 30. Global Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 31. Global Chronic Diseases Management Market Size Share by Application (2021-2026)
Table 32. North America Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Chronic Diseases Management Market Share (2019-2020)
Table 34. North America Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 35. North America Chronic Diseases Management Market Share by Type (2015-2020)
Table 36. North America Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 37. North America Chronic Diseases Management Market Share by Application (2015-2020)
Table 38. Europe Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Chronic Diseases Management Market Share (2019-2020)
Table 40. Europe Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Chronic Diseases Management Market Share by Type (2015-2020)
Table 42. Europe Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Chronic Diseases Management Market Share by Application (2015-2020)
Table 44. China Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 45. China Key Players Chronic Diseases Management Market Share (2019-2020)
Table 46. China Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 47. China Chronic Diseases Management Market Share by Type (2015-2020)
Table 48. China Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 49. China Chronic Diseases Management Market Share by Application (2015-2020)
Table 50. Japan Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Chronic Diseases Management Market Share (2019-2020)
Table 52. Japan Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Chronic Diseases Management Market Share by Type (2015-2020)
Table 54. Japan Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Chronic Diseases Management Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Chronic Diseases Management Market Share (2019-2020)
Table 58. Southeast Asia Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Chronic Diseases Management Market Share by Type (2015-2020)
Table 60. Southeast Asia Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Chronic Diseases Management Market Share by Application (2015-2020)
Table 62. India Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 63. India Key Players Chronic Diseases Management Market Share (2019-2020)
Table 64. India Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 65. India Chronic Diseases Management Market Share by Type (2015-2020)
Table 66. India Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 67. India Chronic Diseases Management Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Chronic Diseases Management Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Chronic Diseases Management Market Share (2019-2020)
Table 70. Central & South America Chronic Diseases Management Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Chronic Diseases Management Market Share by Type (2015-2020)
Table 72. Central & South America Chronic Diseases Management Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Chronic Diseases Management Market Share by Application (2015-2020)
Table 74. TriZetto Corporation Company Details
Table 75. TriZetto Corporation Business Overview
Table 76. TriZetto Corporation Product
Table 77. TriZetto Corporation Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 78. TriZetto Corporation Recent Development
Table 79. Phytel Company Details
Table 80. Phytel Business Overview
Table 81. Phytel Product
Table 82. Phytel Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 83. Phytel Recent Development
Table 84. Pegasystems Company Details
Table 85. Pegasystems Business Overview
Table 86. Pegasystems Product
Table 87. Pegasystems Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 88. Pegasystems Recent Development
Table 89. AxisPoint Health Company Details
Table 90. AxisPoint Health Business Overview
Table 91. AxisPoint Health Product
Table 92. AxisPoint Health Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 93. AxisPoint Health Recent Development
Table 94. Wellcentive Company Details
Table 95. Wellcentive Business Overview
Table 96. Wellcentive Product
Table 97. Wellcentive Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 98. Wellcentive Recent Development
Table 99. Medecision Company Details
Table 100. Medecision Business Overview
Table 101. Medecision Product
Table 102. Medecision Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 103. Medecision Recent Development
Table 104. HealthSmart Holdings Company Details
Table 105. HealthSmart Holdings Business Overview
Table 106. HealthSmart Holdings Product
Table 107. HealthSmart Holdings Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 108. HealthSmart Holdings Recent Development
Table 109. Allscripts Healthcare Solutions Business Overview
Table 110. Allscripts Healthcare Solutions Product
Table 111. Allscripts Healthcare Solutions Company Details
Table 112. Allscripts Healthcare Solutions Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 113. Allscripts Healthcare Solutions Recent Development
Table 114. ZeOmega Company Details
Table 115. ZeOmega Business Overview
Table 116. ZeOmega Product
Table 117. ZeOmega Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 118. ZeOmega Recent Development
Table 119. Epic Corporation Company Details
Table 120. Epic Corporation Business Overview
Table 121. Epic Corporation Product
Table 122. Epic Corporation Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 123. Epic Corporation Recent Development
Table 124. Harmony Information Systems Company Details
Table 125. Harmony Information Systems Business Overview
Table 126. Harmony Information Systems Product
Table 127. Harmony Information Systems Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 128. Harmony Information Systems Recent Development
Table 129. Infosys Company Details
Table 130. Infosys Business Overview
Table 131. Infosys Product
Table 132. Infosys Revenue in Chronic Diseases Management Business (2015-2020) (Million US$)
Table 133. Infosys Recent Development
Table 134. Research Programs/Design for This Report
Table 135. Key Data Information from Secondary Sources
Table 136. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Diseases Management Market Share by Type: 2020 VS 2026
Figure 2. Consulting Service Features
Figure 3. Implementation Service Features
Figure 4. Global Chronic Diseases Management Market Share by Application: 2020 VS 2026
Figure 5. Hospitals Case Studies
Figure 6. Home Care Case Studies
Figure 7. Chronic Diseases Management Report Years Considered
Figure 8. Global Chronic Diseases Management Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Chronic Diseases Management Market Share by Regions: 2020 VS 2026
Figure 10. Global Chronic Diseases Management Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Chronic Diseases Management Market Share by Players in 2019
Figure 13. Global Top Chronic Diseases Management Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Diseases Management as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Chronic Diseases Management Revenue in 2019
Figure 15. North America Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Chronic Diseases Management Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
慢性肺疾患治療の世界市場（～2026年） Lung disease is a very common medical condition that is present in almost every region of the world. Chronic lung diseases can be dangerous and if not treated properly can cause death. The chronic lung diseases cause uneasiness and complications in the respiratory system thus causing difficulty in r…- 慢性肝疾患治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Liver Diseases Therapeutics Market The global Chronic Liver Diseases Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
- クリティカル・慢性ケア製品の世界市場（～2026年） Intensive care products or critical care products are the branch of medicine concerned with the diagnosis and management of life-threatening conditions requiring sophisticated organ support and invasive monitoring whereas chronic care products refers to medical care products which addresses pre-exis…
- 慢性特発性骨髄線維症の世界市場（～2026年） Idiopathic myelofibrosis is a chronic myelo-proliferative disorder and characterized by abnormal mutation of stem cells. This abnormal mutation of stem cells and excessive production of platelets result in development of fibrous tissues within the bone-marrow. This factor would ultimately negatively…
- 慢性尋常性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type…